News
Cosmos Holdings, INC. Announces $3 Million Securities Purchase Agreement with Two Institutional Investors
CHICAGO, IL- - November 16th, 2017 - Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced that it has entered into a $3 million securities purchase agreement with two institutional investors. “We are excited to announce the addition of two institutional investors,” said Grigorios Siokas, President and CEO of Cosmos Holdings. “This agreement will provide us with capital to continue to grow our operations and expand our business.” The securities sold have ...
Cosmos Holdings, Inc. Announces Third Quarter 2017 Results
Revenue Improved 575% and Gross Profit Improved 434% compared to the three months ended September 30, 2016 CHICAGO, IL- - November 20, 2017 - Cosmos Holdings, Inc. ("the Company") (OTCQB: COSMD & COSM), an international pharmaceutical company, announced financial results for the quarter ended September 30, 2017. Highlights: Quarter ended September 30, 2017, versus the quarter ended September 30, 2016, revenue improved 575% to $9.5 million from $1.4 million. Revenue improved sequentially 56%, from $6.1 million in the 2017 ...
Cosmos Holdings, Inc. Announces Second Quarter 2017 Results
Revenue Improved 539% and Gross Profit Improved 487% compared to the three months ended June 30, 2016 CHICAGO, IL- - August 15, 2017 - Cosmos Holdings, Inc. ("the Company") (OTCQB: COSM), an international pharmaceutical company, announced financial results for the quarter ended June 30, 2017. For the quarter ended June 30, 2017, versus the quarter ended June 30, 2016, Cosmos Holdings' revenue improved 539% to $6.1 million from $955 thousand. The increase was mainly on the strength of its SkyPharm SA subsidiary, ...
Business Results Q1 of 2017
Revenue Improved 262% and Gross Profit Improved 315% compared to the three months ended March 31, 2016 For the quarter ended March 31, 2017, versus the quarter ended March 31, 2016, Cosmos Holdings’ revenue improved 262% to $4.1 million from $1.1 million on the strength of its SkyPharm SA subsidiary, which obtained the necessary capital during 2016 and 2017 in order to develop, expand and organically grow its operations. Of note, revenue improved sequentially 27%, from $3.2 million in the 2016 ...
Cosmos Holdings, Inc. Announces first Quarter 2017 Results
Revenue Improved 262% and Gross Profit Improved 315% compared to the three months ended March 31, 2016 For the quarter ended March 31, 2017, versus the quarter ended March 31, 2016, Cosmos Holdings' revenue improved 262% to $4.1 million from $1.1 million on the strength of its SkyPharm SA subsidiary, which obtained the necessary capital during 2016 and 2017 in order to develop, expand and organically grow its operations. Of note, revenue improved sequentially 27%, from $3.2 million in the 2016 ...
Photo
Steve Carr Managing Director

Join our mailing list to stay up to date.

Cosmos-logo